Επικοινωνία
Facebook Instagram

ΠΡΟΣΚΛΗΣΗ ΠΡΟΕΔΡΟΥ

Αγαπητοί σύνεδροι,

Σας προσκαλούμε στο 4ο Συνέδριο Οφθαλμικής Επιφάνειας & Ξηροφθαλμίας να ταξιδέψουμε στον χώρο της Οφθαλμικής Επιφάνειας και της Ξηροφθαλμίας και να ανακαλύψουμε τα καλά κρυμμένα μυστικά της προς όφελος των ασθενών μας.

1η ΑΠΟΤΥΠΩΣΗ 11.04.2017

Να καταφέρουμε να τα «φωτογραφήσουμε» όπως καταφέραμε να φωτογραφήσουμε τις μαύρες τρύπες του διαστήματος, μετά από συντονισμένες επίπονες προσπάθειες, προσπαθώντας να ξεδιπλώσουμε τα δικά τους μυστικά.

Βασισμένοι σε νέες γνώσεις που θα μας προσφέρουν διακεκριμένοι Έλληνες και Ξένοι ομιλητές, θα ταξιδέψουμε απορροφώντας τες για να σχηματίσουμε την εικόνα της ξηροφθαλμίας της νέας εποχής.

Σας περιμένουμε όλους σε αυτό το ταξίδι μεταξύ 4-5 Δεκεμβρίου 2026, στο Μέγαρο Μουσικής Αθηνών, στην αίθουσα Δ. Μητρόπουλος. 

Η ΠΡΟΕΔΡΟΣ

Χ. ΤΕΡΖΙΔΟΥ

Days
Hours
Minutes
Seconds

Reza Dana
MD, MPH, MSc, FARVO

Serge Doan
MD

Χώρος Διεξαγωγής Συνεδρίου

Μέγαρο Διεθνές Συνεδριακό Κέντρο Αθηνών

Σημαντικές Ημερομηνίες

1 Φεβρουαρίου 2026

Έναρξη Εγγραφών

25 Μαΐου 2026

Έναρξη Υποβολής Περιλήψεων

30 Σεπτεμβρίου 2026

Λήξη Προθεσμίας Υποβολής Περιλήψεων

Εγγραφείτε για να λαμβάνετε σημαντικά νέα του συνεδρίου!

Reza Dana, MD, MPH, MSc, FARVO

Claes H. Dohlman Professor of Ophthalmology, Harvard Medical School
Vice Chair for Harvard Department of Ophthalmology
Director, Harvard-Vision Clinical Scientist Development Program
Director, Cornea Service, Mass. Eye and Ear
Senior Scientist, Mass. Eye and Ear/Schepens Eye Research Institute, and Committee on Immunology, Harvard Medical School

Reza Dana holds the Claes Dohlman Chair in Ophthalmology at Harvard Medical School and is Senior Scientist & Director of Cornea at the Massachusetts Eye & Ear, and Vice Chairman of Harvard Department of Ophthalmology. A graduate of Johns Hopkins and Harvard universities, he completed his residency at the Illinois Eye and Ear Infirmary followed by fellowships at Wills Eye Hospital, Mass. Eye and Ear, and Harvard Medical School.

Dr. Dana’s research focuses on the regulation of corneal and ocular surface immunity in transplantation, autoimmunity, wound healing, and regenerative medicine approaches to corneal diseases. His research has led to over 500 publications, which to date have been cited >60,000 times with an h-index of 115; Scholar GPS has ranked Dr. Dana in the top 0.05% of scholars worldwide.
Dr. Dana has trained 150 research postdoctoral and graduate students from 36 countries to date in his laboratory, in addition to over 100 clinical fellows; more than 30 of his trainees have become department/division chiefs.
Dr. Dana is Editor-in-Chief of the scientific journal Cornea.

He has been the recipient of multiple awards, including the Ellis Island Medal of Honor, Special Scholar Award, Physician-Scientist Award, Lew R. Wasserman Award, the Senior Scientific Investigator Award, and Stein Innovation Award from Research to Prevent Blindness, the Cogan and Friedenwald Awards from ARVO, the LSU Chancellor’s Award in Neuroscience and Ophthalmology, the Thygeson Lectureship, the Alcon Research Institute Award, the Kersley Medal (UK), the Endre A. Balazs Prize from ISER, among many others. He was also recipient of the A. Clifford Barger Excellence in Mentoring Award at Harvard Medical School, the highest honor in mentoring awarded to Harvard medical faculty.

Serge DOAN, MD

  • Serge DOAN, MD has performed his medical fellowship in cornea/external diseases in the department of Prof Thanh HOANG-XUAN at Fondation A de Rothschild and Hôpital Bichat in Paris. He is now assistant Professor in this department (Chair, Pr Eric Gabison) since 2000, and leads the ocular surface unit.
  • Author of >100 publications and book chapters on ocular surface diseases, and has written 2 books (in French) on dry eye and allergy.
  • Current ambassador of the Tear Film Ocular Society for France, and former Chair of the Ocular Allergy group at the European Academy of Allergy and Clinical Immunology.

Main publications :

– Mercier M, Doan S, Elaouane I, et al. Omalizumab for severe allergic keratoconjunctivitis: A case series. J Allergy Clin Immunol Pract. Nov 2023;11(11):3528-3530. doi:10.1016/j.jaip.2023.07.016

– Doan S, Papadopoulos NG, Lee JK, et al. Vernal keratoconjunctivitis: Current immunological and clinical evidence and the potential role of omalizumab. World Allergy Organ J. Jun 2023;16(6):100788. doi:10.1016/j.waojou.2023.100788

– Doan S, Arnould L, Febvay C, et al. [Dupilumab-related blepharoconjunctivitis: Recommendations of the CEDRE group. Atopic dermatitis, conjunctivitis and dupilumab: Which management approach?]. J Fr Ophtalmol. Mar 2022;45(3):277-287. doi:10.1016/j.jfo.2021.12.007

– Leonardi A, Doan S, Amrane M, Ismail D, Montero J, Nemeth J, et al. A Randomized, Controlled Trial of Cyclosporine A Cationic Emulsion in Pediatric Vernal Keratoconjunctivitis: The VEKTIS Study. Ophthalmology 2019;126(5):671-681.

– Doan S, Bremond-Gignac D, Chiambaretta F. Comparison of the effect of a hyaluronate-trehalose solution to hyaluronate alone on Ocular Surface Disease Index in patients with moderate to severe dry eye disease. Curr Med Res Opin 2018;34(8):1373-1376.

–     Pisella PJ, Labetoulle M, Doan S, Cochener-Lamard B, Amrane M, Ismail D, et al. Topical ocular 0.1% cyclosporine A cationic emulsion in dry eye disease patients with severe keratitis: experience through the French early-access program. Clin Ophthalmol 2018;12:289-299.      

–     Leonardi A, Doan S, Fauquert JL, Bozkurt B, Allegri P, Marmouz F, et al. Diagnostic tools in ocular allergy. Allergy 2017;72(10):1485-1498.

–     Doan S, Amat F, Gabison E, Saf S, Cochereau I, Just J. Omalizumab in Severe Refractory Vernal Keratoconjunctivitis in Children: Case Series and Review of the Literature. Ophthalmol Ther 2016.

–     Doan S, Chiambaretta F, Baudouin C. Evaluation of an eyelid warming device (Blephasteam) for the management of ocular surface diseases in France: the ESPOIR study. J Fr Ophtalmol 2014;37(10):763-72

–     Doan S, Gabison E, Chiambaretta F, Touati M, Cochereau I. Efficacy of azithromycin 1.5% eye drops in childhood ocular rosacea with phlyctenular blepharokeratoconjunctivitis. J Ophthalmic Inflamm Infect 2013;3(1):38.

–     Munyangango EM, Le Roux-Villet C, Doan S, Pascal F, Soued I, Alexandre M, et al. Oral cyclophosphamide without corticosteroids to treat mucous membrane pemphigoid. Br J Dermatol 2013;168(2):381-90.

–     Taille C, Doan S, Neukirch C, Aubier M. Omalizumab for severe atopic keratoconjunctivitis. BMJ Case Rep 2010;2010.

–     Zribi H, Descamps V, Hoang-Xuan T, Crickx B, Doan S. Dramatic improvement of atopic keratoconjunctivitis after topical treatment with tacrolimus ointment restricted to the eyelids. J Eur Acad Dermatol Venereol 2008.

–     S Doan, E Gabison, S Nghiem-Buffet, O Abitbol, D Gatinel, T Hoang-Xuan. Long-term Visual Outcome of Childhood lepharokeratoconjunctivitis. Am J Ophthalmol. 2007; 143(3):528-9.

–     Doan S, Gabison E, Abitbol O, Gatinel D, Chast F, Hoang-Xuan T. [Efficacy of topical 2% cyclosporine A as a steroid-sparing agent in steroid-dependent vernal keratoconjunctivitis]. J Fr Ophtalmol 2007;30(7):697-701.

–     Doan S, Gabison E, Gatinel D, Duong MH, Abitbol O, Hoang-Xuan T. Topical cyclosporine A in severe steroid-dependent childhood phlyctenular keratoconjunctivitis. Am J Ophthalmol. 2006 Jan;141(1):62-66.

Dr. Jurado-Fasoli

Dr. Jurado-Fasoli is an Assistant Professor in the Department of Physiology at the University of Granada, Spain, and a researcher at the Sport and Health University Research Institute (iMUDS). He holds a PhD in Biomedicine from the University ofGranada and is a Registered Dietitian-Nutritionist. His research focuses on human physiology, nutrition, dietary supplementation, and exercise, particularly in relation to metabolic health and performance. He has authored more than 80 peer-reviewed scientific papers, many in top-quartile journals, and has received several distinctions, including the Best Doctoral Thesis Award (2023–2024) from the Spanish Society of Physiological Sciences. Dr. Jurado-Fasoli has conducted research stays in leading institutions such as Yale University, Leiden University Medical Center, and Chalmers University of Technology, and has active collaborations with international research groups. His work aims to advance precision nutrition strategies for improving health and physical performance.

Prof. Eric Robinson

Eric is a Professor of Psychology & Public Health at the University of Liverpool, UK. His research examines how food policy can be used to improve population diet and reduce obesity. His work has directly informed and evaluated national dietary policy, as well as being recognised by the World Obesity Federation (Outstanding New Faculty Member, 2016) and leading national, European and international scientific societies (2010-2024).

Dr. Mark Hopkins

Dr. Mark Hopkins is an Associate Professor of Nutritional Physiology and an UKRI Future Leaders Fellow within the School of Food Science & Nutrition, University of Leeds, UK. His work aims to link whole-body metabolism and psychological function with human behavior to gain a better understanding of how eating behavior is shaped by our physiology, and how these relationships are altered under differing conditions of energy balance. In particular, he is interested in 1) the relationships between body composition, energy expenditure and appetite control, 2) the role of fat-free mass and resting metabolic rate on the control of appetite, 3) the impact of exercise on appetite control, and 4) the biological and behavioral compensatory mechanisms that resist diet and exercise-induced weight loss.
Mark has published extensively in the areas of human appetite, energy balance and obesity, with >100 peer-reviewed research articles, a Scopus H-index of 35 (Google Scholar = 42), and >3900 Scopus citations (Google Scholar >6600). He has successfully obtained £4.9 million in research funding, including £2.4 million as PI (UKRI Future Leaders Fellowship; Wellcome) and £2.5 million as Co-I (National Institute for Health Research; White Rose University Consortium). He has authored two expert position statements on exercise and appetite control for the British Association of Sport & Exercise Sciences (the professional body for sport and exercise sciences in the UK) and is an author on the recent American College of Sports Medicine’s consensus statement on Physical Activity and Excess Body Weight and Adiposity for Adults. He is the Network Lead for the Association for the Study of Obesity Yorkshire Region, and a steering committee member for the BBSRC ORIC Research Hub, INFORM, and the Movement and Physical Activity Interdisciplinary Research Network at the University of Leeds, UK.